Fostering Rare Cancer Drug Development
The TargetCancer Foundation Industry Roundtable is a bi-annual invitation-only meeting that unites partners in the rare cancer and tissue-agnostic drug development spaces. This highly interactive, discussion-based meeting allows companies to discuss common challenges and opportunities for collaboration. In addition, key research, clinical, regulatory, and other stakeholders from the TargetCancer Foundation community attend and provide their perspectives. The initiatives generated through these action-oriented meetings are developed and led by TargetCancer Foundation.
2025 Industry Roundtable
Our fourth Industry Roundtable took place in October 2025, and focused on TCF’s advocacy efforts for developing tissue-agnostic clinical treatment guidelines, as well as the current political and regulatory environment and its impact on the development and approval of rare cancer and tissue-agnostic treatments.
Thank You to our 2025 Industry Roundtable Participating Companies:
Join our Mailing List
TargetCancer Foundation
TargetCancer Foundation is a recognized 501(c)(3) charity, Tax ID 26-4510094.
All content and images copyright © 2026 TargetCancer Foundation. All rights reserved. | Privacy Policy